Casana R, Tolva VS, Odero A, et al. - To report the outcomes of carotid artery stenting (CAS) in symptomatic patients with and without acute coronary syndrome (ACS), researchers analyzed 151 consecutive symptomatic patients who had CAS between 2010 and 2017 in a single institution. The presence of ACS was detected in 66 (43.7%). In terms of rates of death, stroke, myocardial infarction (MI), and restenosis, no significant disparities were evident between patients with and without ACS in the short‐term follow‐up. A long‐term follow‐up revealed higher rates of mortality and MI in patients with ACS, due to the complexity of these patients. Overall, findings demonstrated the safety as well as the effectiveness of CAS as a management option for patients with symptomatic carotid artery stenosis, who recently received percutaneous transluminal coronary angioplasty for ACS, needing uninterrupted dual antiplatelet therapy.